+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Pet Cancer Therapeutics Market by Distribution Channel (Online Pharmacies, Specialty Clinics, Veterinary Hospitals), Animal Type (Cats, Dogs), Drug Class, Therapy Type, Formulation, Line of Therapy, Cancer Type - Global Forecast 2025-2030- Product Image
Pet Cancer Therapeutics Market by Distribution Channel (Online Pharmacies, Specialty Clinics, Veterinary Hospitals), Animal Type (Cats, Dogs), Drug Class, Therapy Type, Formulation, Line of Therapy, Cancer Type - Global Forecast 2025-2030- Product Image
Sale

Pet Cancer Therapeutics Market by Distribution Channel (Online Pharmacies, Specialty Clinics, Veterinary Hospitals), Animal Type (Cats, Dogs), Drug Class, Therapy Type, Formulation, Line of Therapy, Cancer Type - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 198 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6118757
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Senior leaders navigating the pet cancer therapeutics market face a landscape defined by rapid innovation, regulatory shifts, and a growing need for collaboration across the veterinary healthcare ecosystem. This report delivers actionable, data-led insights tailored for strategic decision-making in an evolving sector where treatment advances, supply chain strategies, and market differentiation are critical.

Market Snapshot: Pet Cancer Therapeutics Sector

The pet cancer therapeutics market is witnessing notable growth as molecular diagnostics and targeted therapies enable more precise, data-driven treatment approaches for companion animals. Emerging technologies, including immunotherapy and bioinformatics-powered diagnostics, are fundamentally shifting therapeutic pipelines and clinical protocols. Extensive integration of digital health platforms and telemedicine is improving both patient monitoring and continuity of care, impacting key stakeholders across veterinary clinics, pharmaceutical manufacturers, and biotech innovators. This complex market features a dynamic value chain, further influenced by global regulatory and macroeconomic developments.

Scope & Segmentation

This report provides a comprehensive breakdown of the pet cancer therapeutics market, analyzing its many segments, geographic variances, and enabling technologies to support informed decision-making.

  • Distribution Channels: Online pharmacies, specialty clinics, and veterinary hospitals, each with distinct regulatory and operational structures.
  • Animal Types: Dedicated solutions tailored to cats and dogs, highlighting species-specific treatment needs and approaches.
  • Drug Classes: Biologics and small molecule therapeutics, distinguished by molecular profiles and treatment mechanisms.
  • Therapy Methods: Chemotherapy, immunotherapy, radiation therapy, surgery, and targeted therapy covering the full spectrum of intervention options.
  • Formulations: Injectable, oral, and topical delivery forms, supporting both inpatient and outpatient administration.
  • Line of Therapy: Strategies include first-line, palliative, and second-line interventions, each addressing different stages and outcomes in clinical care.
  • Cancer Variations: Coverage includes hemangiosarcoma, lymphoma, mast cell tumors, melanoma, and osteosarcoma, with research attention on disease-specific protocols.
  • Regions: Analysis spans the Americas (United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (notable countries include United Kingdom, Germany, France, UAE, South Africa), and Asia-Pacific (China, India, Japan, Australia, South Korea, among others).
  • Key Players: Profiles companies such as Zoetis Inc., Elanco Animal Health Incorporated, Virbac S.A., Boehringer Ingelheim International GmbH, Ceva Santé Animale S.A., Dechra Pharmaceuticals PLC, Vetoquinol S.A., Kindred Biosciences, Inc., VetDC, Inc., and OPKO Health, Inc.

Key Takeaways: Strategic Directions in Pet Cancer Therapeutics

  • Innovation is rapidly advancing with the increased adoption of immunotherapies and precision medicine tools, improving both specificity and patient outcomes in veterinary oncology.
  • Collaborative frameworks between biotech firms and clinical networks are expediting clinical trial enrollment and broadening access to advanced therapies.
  • Real-time data capture through wearables and digital solutions is enabling proactive treatment monitoring and enhancing pet quality of life while supporting adherence to long-term regimens.
  • The oncology care continuum for companion animals is evolving to mirror advanced models in human medicine, with integrated adjunctive and palliative care practices now standard in many settings.
  • Differentiation by regional infrastructure, regulatory environment, and market maturity underscores the need for context-specific strategies in product positioning and market entry.

Tariff Impact: Responding to Evolving Trade and Supply Chain Dynamics

New United States tariffs on select pharmaceutical imports in 2025 are intensifying cost pressures and prompting both manufacturers and distributors in the pet cancer therapeutics space to adopt agile procurement and inventory models. Enhanced investment in domestic manufacturing and joint ventures with contract research organizations aim to mitigate supply chain disruptions while supporting continuity of care at the clinical level. Stakeholders are adapting distribution strategies and exploring bundled or outcome-based pricing to balance cost containment with the imperative to deliver innovative therapies.

Research Methodology & Data Sources

This report integrates primary interviews with veterinary specialists and industry executives, structured field visits, and a broad analysis of proprietary databases covering clinical trials, regulatory filings, and peer-reviewed journals. Established frameworks, including Porter’s Five Forces and SWOT analysis, guide the evaluation of competitive intensity and unmet clinical needs across companion animal oncology.

Why This Report Matters

  • Enables senior leaders to align R&D investments and market strategies with fast-evolving clinical and regulatory trends.
  • Supports informed decision-making through in-depth segmentation insights and profiles on high-impact regional and segment variations.
  • Empowers executives to navigate supply chain complexities and drive adoption of high-value therapies through evidence-based recommendations.

Conclusion

Equipped with a nuanced understanding of segment trends, stakeholder priorities, and regulatory shifts, decision-makers are positioned to capitalize on emerging opportunities in pet cancer therapeutics. Continued innovation, robust collaboration, and strategic agility will define future market success.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Expansion of targeted kinase inhibitors for canine lymphoma with improved safety profiles
5.2. Rising adoption of immunotherapy vaccines for treating feline injection site sarcomas
5.3. Integration of liquid biopsy diagnostics to enable early detection of pet cancers
5.4. Growth of personalized medicine platforms for species-specific oncology treatment
5.5. Partnerships between veterinary clinics and biotech firms for novel oncology drugs
5.6. Increased focus on palliative care products enhancing quality of life for terminal pets
5.7. Development of minimally invasive surgical techniques supported by advanced imaging modalities
5.8. Surge in venture capital investment fueling R&D in next-generation animal oncology therapeutics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Pet Cancer Therapeutics Market, by Distribution Channel
8.1. Introduction
8.2. Online Pharmacies
8.3. Specialty Clinics
8.4. Veterinary Hospitals
9. Pet Cancer Therapeutics Market, by Animal Type
9.1. Introduction
9.2. Cats
9.3. Dogs
10. Pet Cancer Therapeutics Market, by Drug Class
10.1. Introduction
10.2. Biologics
10.3. Small Molecules
11. Pet Cancer Therapeutics Market, by Therapy Type
11.1. Introduction
11.2. Chemotherapy
11.3. Immunotherapy
11.4. Radiation Therapy
11.5. Surgery
11.6. Targeted Therapy
12. Pet Cancer Therapeutics Market, by Formulation
12.1. Introduction
12.2. Injectable
12.3. Oral
12.4. Topical
13. Pet Cancer Therapeutics Market, by Line Of Therapy
13.1. Introduction
13.2. First Line
13.3. Palliative
13.4. Second Line
14. Pet Cancer Therapeutics Market, by Cancer Type
14.1. Introduction
14.2. Hemangiosarcoma
14.3. Lymphoma
14.4. Mast Cell Tumors
14.5. Melanoma
14.6. Osteosarcoma
15. Americas Pet Cancer Therapeutics Market
15.1. Introduction
15.2. United States
15.3. Canada
15.4. Mexico
15.5. Brazil
15.6. Argentina
16. Europe, Middle East & Africa Pet Cancer Therapeutics Market
16.1. Introduction
16.2. United Kingdom
16.3. Germany
16.4. France
16.5. Russia
16.6. Italy
16.7. Spain
16.8. United Arab Emirates
16.9. Saudi Arabia
16.10. South Africa
16.11. Denmark
16.12. Netherlands
16.13. Qatar
16.14. Finland
16.15. Sweden
16.16. Nigeria
16.17. Egypt
16.18. Turkey
16.19. Israel
16.20. Norway
16.21. Poland
16.22. Switzerland
17. Asia-Pacific Pet Cancer Therapeutics Market
17.1. Introduction
17.2. China
17.3. India
17.4. Japan
17.5. Australia
17.6. South Korea
17.7. Indonesia
17.8. Thailand
17.9. Philippines
17.10. Malaysia
17.11. Singapore
17.12. Vietnam
17.13. Taiwan
18. Competitive Landscape
18.1. Market Share Analysis, 2024
18.2. FPNV Positioning Matrix, 2024
18.3. Competitive Analysis
18.3.1. Zoetis Inc.
18.3.2. Elanco Animal Health Incorporated
18.3.3. Virbac S.A.
18.3.4. Boehringer Ingelheim International GmbH
18.3.5. Ceva Santé Animale S.A.
18.3.6. Dechra Pharmaceuticals PLC
18.3.7. Vetoquinol S.A.
18.3.8. Kindred Biosciences, Inc.
18.3.9. VetDC, Inc.
18.3.10. OPKO Health, Inc.
19. ResearchAI
20. ResearchStatistics
21. ResearchContacts
22. ResearchArticles
23. Appendix
List of Figures
FIGURE 1. PET CANCER THERAPEUTICS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL PET CANCER THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL PET CANCER THERAPEUTICS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL PET CANCER THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL PET CANCER THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 6. GLOBAL PET CANCER THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL PET CANCER THERAPEUTICS MARKET SIZE, BY ANIMAL TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL PET CANCER THERAPEUTICS MARKET SIZE, BY ANIMAL TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL PET CANCER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2024 VS 2030 (%)
FIGURE 10. GLOBAL PET CANCER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL PET CANCER THERAPEUTICS MARKET SIZE, BY THERAPY TYPE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL PET CANCER THERAPEUTICS MARKET SIZE, BY THERAPY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL PET CANCER THERAPEUTICS MARKET SIZE, BY FORMULATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL PET CANCER THERAPEUTICS MARKET SIZE, BY FORMULATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL PET CANCER THERAPEUTICS MARKET SIZE, BY LINE OF THERAPY, 2024 VS 2030 (%)
FIGURE 16. GLOBAL PET CANCER THERAPEUTICS MARKET SIZE, BY LINE OF THERAPY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL PET CANCER THERAPEUTICS MARKET SIZE, BY CANCER TYPE, 2024 VS 2030 (%)
FIGURE 18. GLOBAL PET CANCER THERAPEUTICS MARKET SIZE, BY CANCER TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS PET CANCER THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS PET CANCER THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES PET CANCER THERAPEUTICS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES PET CANCER THERAPEUTICS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA PET CANCER THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA PET CANCER THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC PET CANCER THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC PET CANCER THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. PET CANCER THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. PET CANCER THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 29. PET CANCER THERAPEUTICS MARKET: RESEARCHAI
FIGURE 30. PET CANCER THERAPEUTICS MARKET: RESEARCHSTATISTICS
FIGURE 31. PET CANCER THERAPEUTICS MARKET: RESEARCHCONTACTS
FIGURE 32. PET CANCER THERAPEUTICS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. PET CANCER THERAPEUTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL PET CANCER THERAPEUTICS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL PET CANCER THERAPEUTICS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL PET CANCER THERAPEUTICS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL PET CANCER THERAPEUTICS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL PET CANCER THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL PET CANCER THERAPEUTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL PET CANCER THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL PET CANCER THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL PET CANCER THERAPEUTICS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL PET CANCER THERAPEUTICS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL PET CANCER THERAPEUTICS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL PET CANCER THERAPEUTICS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL PET CANCER THERAPEUTICS MARKET SIZE, BY VETERINARY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL PET CANCER THERAPEUTICS MARKET SIZE, BY VETERINARY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL PET CANCER THERAPEUTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL PET CANCER THERAPEUTICS MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL PET CANCER THERAPEUTICS MARKET SIZE, BY CATS, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL PET CANCER THERAPEUTICS MARKET SIZE, BY CATS, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL PET CANCER THERAPEUTICS MARKET SIZE, BY DOGS, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL PET CANCER THERAPEUTICS MARKET SIZE, BY DOGS, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL PET CANCER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL PET CANCER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL PET CANCER THERAPEUTICS MARKET SIZE, BY BIOLOGICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL PET CANCER THERAPEUTICS MARKET SIZE, BY BIOLOGICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL PET CANCER THERAPEUTICS MARKET SIZE, BY SMALL MOLECULES, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL PET CANCER THERAPEUTICS MARKET SIZE, BY SMALL MOLECULES, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL PET CANCER THERAPEUTICS MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL PET CANCER THERAPEUTICS MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL PET CANCER THERAPEUTICS MARKET SIZE, BY CHEMOTHERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL PET CANCER THERAPEUTICS MARKET SIZE, BY CHEMOTHERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL PET CANCER THERAPEUTICS MARKET SIZE, BY IMMUNOTHERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL PET CANCER THERAPEUTICS MARKET SIZE, BY IMMUNOTHERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL PET CANCER THERAPEUTICS MARKET SIZE, BY RADIATION THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL PET CANCER THERAPEUTICS MARKET SIZE, BY RADIATION THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL PET CANCER THERAPEUTICS MARKET SIZE, BY SURGERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL PET CANCER THERAPEUTICS MARKET SIZE, BY SURGERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL PET CANCER THERAPEUTICS MARKET SIZE, BY TARGETED THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL PET CANCER THERAPEUTICS MARKET SIZE, BY TARGETED THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL PET CANCER THERAPEUTICS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL PET CANCER THERAPEUTICS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL PET CANCER THERAPEUTICS MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL PET CANCER THERAPEUTICS MARKET SIZE, BY INJECTABLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL PET CANCER THERAPEUTICS MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL PET CANCER THERAPEUTICS MARKET SIZE, BY ORAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL PET CANCER THERAPEUTICS MARKET SIZE, BY TOPICAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL PET CANCER THERAPEUTICS MARKET SIZE, BY TOPICAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL PET CANCER THERAPEUTICS MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL PET CANCER THERAPEUTICS MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL PET CANCER THERAPEUTICS MARKET SIZE, BY FIRST LINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL PET CANCER THERAPEUTICS MARKET SIZE, BY FIRST LINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL PET CANCER THERAPEUTICS MARKET SIZE, BY PALLIATIVE, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL PET CANCER THERAPEUTICS MARKET SIZE, BY PALLIATIVE, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL PET CANCER THERAPEUTICS MARKET SIZE, BY SECOND LINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL PET CANCER THERAPEUTICS MARKET SIZE, BY SECOND LINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL PET CANCER THERAPEUTICS MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL PET CANCER THERAPEUTICS MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL PET CANCER THERAPEUTICS MARKET SIZE, BY HEMANGIOSARCOMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL PET CANCER THERAPEUTICS MARKET SIZE, BY HEMANGIOSARCOMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL PET CANCER THERAPEUTICS MARKET SIZE, BY LYMPHOMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL PET CANCER THERAPEUTICS MARKET SIZE, BY LYMPHOMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL PET CANCER THERAPEUTICS MARKET SIZE, BY MAST CELL TUMORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL PET CANCER THERAPEUTICS MARKET SIZE, BY MAST CELL TUMORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL PET CANCER THERAPEUTICS MARKET SIZE, BY MELANOMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL PET CANCER THERAPEUTICS MARKET SIZE, BY MELANOMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL PET CANCER THERAPEUTICS MARKET SIZE, BY OSTEOSARCOMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL PET CANCER THERAPEUTICS MARKET SIZE, BY OSTEOSARCOMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. AMERICAS PET CANCER THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 70. AMERICAS PET CANCER THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 71. AMERICAS PET CANCER THERAPEUTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 72. AMERICAS PET CANCER THERAPEUTICS MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 73. AMERICAS PET CANCER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 74. AMERICAS PET CANCER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS PET CANCER THERAPEUTICS MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS PET CANCER THERAPEUTICS MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS PET CANCER THERAPEUTICS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS PET CANCER THERAPEUTICS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS PET CANCER THERAPEUTICS MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS PET CANCER THERAPEUTICS MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS PET CANCER THERAPEUTICS MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS PET CANCER THERAPEUTICS MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS PET CANCER THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS PET CANCER THERAPEUTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 85. UNITED STATES PET CANCER THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 86. UNITED STATES PET CANCER THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 87. UNITED STATES PET CANCER THERAPEUTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 88. UNITED STATES PET CANCER THERAPEUTICS MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 89. UNITED STATES PET CANCER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 90. UNITED STATES PET CANCER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 91. UNITED STATES PET CANCER THERAPEUTICS MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 92. UNITED STATES PET CANCER THERAPEUTICS MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 93. UNITED STATES PET CANCER THERAPEUTICS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 94. UNITED STATES PET CANCER THERAPEUTICS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 95. UNITED STATES PET CANCER THERAPEUTICS MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 96. UNITED STATES PET CANCER THERAPEUTICS MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 97. UNITED STATES PET CANCER THERAPEUTICS MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 98. UNITED STATES PET CANCER THERAPEUTICS MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 99. UNITED STATES PET CANCER THERAPEUTICS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 100. UNITED STATES PET CANCER THERAPEUTICS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 101. CANADA PET CANCER THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 102. CANADA PET CANCER THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 103. CANADA PET CANCER THERAPEUTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 104. CANADA PET CANCER THERAPEUTICS MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 105. CANADA PET CANCER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 106. CANADA PET CANCER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 107. CANADA PET CANCER THERAPEUTICS MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 108. CANADA PET CANCER THERAPEUTICS MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 109. CANADA PET CANCER THERAPEUTICS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 110. CANADA PET CANCER THERAPEUTICS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 111. CANADA PET CANCER THERAPEUTICS MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 112. CANADA PET CANCER THERAPEUTICS MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 113. CANADA PET CANCER THERAPEUTICS MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 114. CANADA PET CANCER THERAPEUTICS MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 115. MEXICO PET CANCER THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 116. MEXICO PET CANCER THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 117. MEXICO PET CANCER THERAPEUTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 118. MEXICO PET CANCER THERAPEUTICS MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 119. MEXICO PET CANCER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 120. MEXICO PET CANCER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 121. MEXICO PET CANCER THERAPEUTICS MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 122. MEXICO PET CANCER THERAPEUTICS MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 123. MEXICO PET CANCER THERAPEUTICS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 124. MEXICO PET CANCER THERAPEUTICS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 125. MEXICO PET CANCER THERAPEUTICS MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 126. MEXICO PET CANCER THERAPEUTICS MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 127. MEXICO PET CANCER THERAPEUTICS MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 128. MEXICO PET CANCER THERAPEUTICS MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 129. BRAZIL PET CANCER THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 130. BRAZIL PET CANCER THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 131. BRAZIL PET CANCER THERAPEUTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 132. BRAZIL PET CANCER THERAPEUTICS MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 133. BRAZIL PET CANCER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 134. BRAZIL PET CANCER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 135. BRAZIL PET CANCER THERAPEUTICS MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 136. BRAZIL PET CANCER THERAPEUTICS MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 137. BRAZIL PET CANCER THERAPEUTICS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 138. BRAZIL PET CANCER THERAPEUTICS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 139. BRAZIL PET CANCER THERAPEUTICS MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 140. BRAZIL PET CANCER THERAPEUTICS MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 141. BRAZIL PET CANCER THERAPEUTICS MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 142. BRAZIL PET CANCER THERAPEUTICS MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 143. ARGENTINA PET CANCER THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 144. ARGENTINA PET CANCER THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 145. ARGENTINA PET CANCER THERAPEUTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 146. ARGENTINA PET CANCER THERAPEUTICS MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 147. ARGENTINA PET CANCER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 148. ARGENTINA PET CANCER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 149. ARGENTINA PET CANCER THERAPEUTICS MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 150. ARGENTINA PET CANCER THERAPEUTICS MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 151. ARGENTINA PET CANCER THERAPEUTICS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 152. ARGENTINA PET CANCER THERAPEUTICS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 153. ARGENTINA PET CANCER THERAPEUTICS MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 154. ARGENTINA PET CANCER THERAPEUTICS MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 155. ARGENTINA PET CANCER THERAPEUTICS MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 156. ARGENTINA PET CANCER THERAPEUTICS MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA PET CANCER THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 158. EUROPE, MIDDLE EAST & AFRICA PET CANCER THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 159. EUROPE, MIDDLE EAST & AFRICA PET CANCER THERAPEUTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 160. EUROPE, MIDDLE EAST & AFRICA PET CANCER THERAPEUTICS MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 161. EUROPE, MIDDLE EAST & AFRICA PET CANCER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 162. EUROPE, MIDDLE EAST & AFRICA PET CANCER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 163. EUROPE, MIDDLE EAST & AFRICA PET CANCER THERAPEUTICS MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 164. EUROPE, MIDDLE EAST & AFRICA PET CANCER THERAPEUTICS MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 165. EUROPE, MIDDLE EAST & AFRICA PET CANCER THERAPEUTICS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 166. EUROPE, MIDDLE EAST & AFRICA PET CANCER THERAPEUTICS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 167. EUROPE, MIDDLE EAST & AFRICA PET CANCER THERAPEUTICS MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 168. EUROPE, MIDDLE EAST & AFRICA PET CANCER THERAPEUTICS MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 169. EUROPE, MIDDLE EAST & AFRICA PET CANCER THERAPEUTICS MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 170. EUROPE, MIDDLE EAST & AFRICA PET CANCER THERAPEUTICS MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA PET CANCER THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA PET CANCER THERAPEUTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 173. UNITED KINGDOM PET CANCER THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 174. UNITED KINGDOM PET CANCER THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 175. UNITED KINGDOM PET CANCER THERAPEUTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 176. UNITED KINGDOM PET CANCER THERAPEUTICS MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 177. UNITED KINGDOM PET CANCER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 178. UNITED KINGDOM PET CANCER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 179. UNITED KINGDOM PET CANCER THERAPEUTICS MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 180. UNITED KINGDOM PET CANCER THERAPEUTICS MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 181. UNITED KINGDOM PET CANCER THERAPEUTICS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 182. UNITED KINGDOM PET CANCER THERAPEUTICS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 183. UNITED KINGDOM PET CANCER THERAPEUTICS MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 184. UNITED KINGDOM PET CANCER THERAPEUTICS MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 185. UNITED KINGDOM PET CANCER THERAPEUTICS MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 186. UNITED KINGDOM PET CANCER THERAPEUTICS MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 187. GERMANY PET CANCER THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 188. GERMANY PET CANCER THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 189. GERMANY PET CANCER THERAPEUTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 190. GERMANY PET CANCER THERAPEUTICS MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 191. GERMANY PET CANCER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 192. GERMANY PET CANCER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 193. GERMANY PET CANCER THERAPEUTICS MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 194. GERMANY PET CANCER THERAPEUTICS MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 195. GERMANY PET CANCER THERAPEUTICS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 196. GERMANY PET CANCER THERAPEUTICS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 197. GERMANY PET CANCER THERAPEUTICS MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 198. GERMANY PET CANCER THERAPEUTICS MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 199. GERMANY PET CANCER THERAPEUTICS MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 200. GERMANY PET CANCER THERAPEUTICS MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 201. FRANCE PET CANCER THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 202. FRANCE PET CANCER THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 203. FRANCE PET CANCER THERAPEUTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 204. FRANCE PET CANCER THERAPEUTICS MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 205. FRANCE PET CANCER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 206. FRANCE PET CANCER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 207. FRANCE PET CANCER THERAPEUTICS MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 208. FRANCE PET CANCER THERAPEUTICS MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 209. FRANCE PET CANCER THERAPEUTICS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 210. FRANCE PET CANCER THERAPEUTICS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 211. FRANCE PET CANCER THERAPEUTICS MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 212. FRANCE PET CANCER THERAPEUTICS MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 213. FRANCE PET CANCER THERAPEUTICS MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 214. FRANCE PET CANCER THERAPEUTICS MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 215. RUSSIA PET CANCER THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 216. RUSSIA PET CANCER THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 217. RUSSIA PET CANCER THERAPEUTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 218. RUSSIA PET CANCER THERAPEUTICS MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 219. RUSSIA PET CANCER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 220. RUSSIA PET CANCER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 221. RUSSIA PET CANCER THERAPEUTICS MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 222. RUSSIA PET CANCER THERAPEUTICS MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 223. RUSSIA PET CANCER THERAPEUTICS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 224. RUSSIA PET CANCER THERAPEUTICS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 225. RUSSIA PET CANCER THERAPEUTICS MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 226. RUSSIA PET CANCER THERAPEUTICS MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 227. RUSSIA PET CANCER THERAPEUTICS MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 228. RUSSIA PET CANCER THERAPEUTICS MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 229. ITALY PET CANCER THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 230. ITALY PET CANCER THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 231. ITALY PET CANCER THERAPEUTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 232. ITALY PET CANCER THERAPEUTICS MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 233. ITALY PET CANCER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 234. ITALY PET CANCER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 235. ITALY PET CANCER THERAPEUTICS MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 236. ITALY PET CANCER THERAPEUTICS MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 237. ITALY PET CANCER THERAPEUTICS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 238. ITALY PET CANCER THERAPEUTICS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 239. ITALY PET CANCER THERAPEUTICS MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 240. ITALY PET CANCER THERAPEUTICS MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 241. ITALY PET CANCER THERAPEUTICS MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 242. ITALY PET CANCER THERAPEUTICS MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 243. SPAIN PET CANCER THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 244. SPAIN PET CANCER THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 245. SPAIN PET CANCER THERAPEUTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 246. SPAIN PET CANCER THERAPEUTICS MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 247. SPAIN PET CANCER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 248. SPAIN PET CANCER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 249. SPAIN PET CANCER THERAPEUTICS MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 250. SPAIN PET CANCER THERAPEUTICS MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 251. SPAIN PET CANCER THERAPEUTICS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 252. SPAIN PET CANCER THERAPEUTICS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 253. SPAIN PET CANCER THERAPEUTICS MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 254. SPAIN PET CANCER THERAPEUTICS MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 255. SPAIN PET CANCER THERAPEUTICS MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 256. SPAIN PET CANCER THERAPEUTICS MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 257. UNITED ARAB EMIRATES PET CANCER THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 258. UNITED ARAB EMIRATES PET CANCER THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 259. UNITED ARAB EMIRATES PET CANCER THERAPEUTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 260. UNITED ARAB EMIRATES PET CANCER THERAPEUTICS MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 261. UNITED ARAB EMIRATES PET CANCER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 262. UNITED ARAB EMIRATES PET CANCER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 263. UNITED ARAB EMIRATES PET CANCER THERAPEUTICS MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 264. UNITED ARAB EMIRATES PET CANCER THERAPEUTICS MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 265. UNITED ARAB EMIRATES PET CANCER THERAPEUTICS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 266. UNITED ARAB EMIRATES PET CANCER THERAPEUTICS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 267. UNITED ARAB EMIRATES PET CANCER THERAPEUTICS MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 268. UNITED ARAB EMIRATES PET CANCER THERAPEUTICS MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 269. UNITED ARAB EMIRATES PET CANCER THERAPEUTICS MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 270. UNITED ARAB EMIRATES PET CANCER THERAPEUTICS MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 271. SAUDI ARABIA PET CANCER THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 272. SAUDI ARABIA PET CANCER THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 273. SAUDI ARABIA PET CANCER THERAPEUTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 274. SAUDI ARABIA PET CANCER THERAPEUTICS MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 275. SAUDI ARABIA PET CANCER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 276. SAUDI ARABIA PET CANCER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 277. SAUDI ARABIA PET CANCER THERAPEUTICS MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 278. SAUDI ARABIA PET CANCER THERAPEUTICS MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 279. SAUDI ARABIA PET CANCER THERAPEUTICS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 280. SAUDI ARABIA PET CANCER THERAPEUTICS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 281. SAUDI ARABIA PET CANCER THERAPEUTICS MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 282. SAUDI ARABIA PET CANCER THERAPEUTICS MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 283. SAUDI ARABIA PET CANCER THERAPEUTICS MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 284. SAUDI ARABIA PET CANCER THERAPEUTICS MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 285. SOUTH AFRICA PET CANCER THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 286. SOUTH AFRICA PET CANCER THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 287. SOUTH AFRICA PET CANCER THERAPEUTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 288. SOUTH AFRICA PET CANCER THERAPEUTICS MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 289. SOUTH AFRICA PET CANCER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 290. SOUTH AFRICA PET CANCER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 291. SOUTH AFRICA PET CANCER THERAPEUTICS MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 292. SOUTH AFRICA PET CANCER THERAPEUTICS MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 293. SOUTH AFRICA PET CANCER THERAPEUTICS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 294. SOUTH AFRICA PET CANCER THERAPEUTICS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 295. SOUTH AFRICA PET CANCER THERAPEUTICS MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 296. SOUTH AFRICA PET CANCER THERAPEUTICS MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 297. SOUTH AFRICA PET CANCER THERAPEUTICS MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 298. SOUTH AFRICA PET CANCER THERAPEUTICS MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 299. DENMARK PET CANCER THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 300. DENMARK PET CANCER THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 301. DENMARK PET CANCER THERAPEUTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 302. DENMARK PET CANCER THERAPEUTICS MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 303. DENMARK PET CANCER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 304. DENMARK PET CANCER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 305. DENMARK PET CANCER THERAPEUTICS MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 306. DENMARK PET CANCER THERAPEUTICS MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 307. DENMARK PET CANCER THERAPEUTICS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 308. DENMARK PET CANCER THERAPEUTICS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 309. DENMARK PET CANCER THERAPEUTICS MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 310. DENMARK PET CANCER THERAPEUTICS MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 311. DENMARK PET CANCER THERAPEUTICS MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 312. DENMARK PET CANCER THERAPEUTICS MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 313. NETHERLANDS PET CANCER THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 314. NETHERLANDS PET CANCER THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 315. NETHERLANDS PET CANCER THERAPEUTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 316. NETHERLANDS PET CANCER THERAPEUTICS MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 317. NETHERLANDS PET CANCER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 318. NETHERLANDS PET CANCER THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 319. NETHERLANDS PET CANCER THERAPEUTICS MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 320. NETHERLANDS PET CANCER THERAPEUTICS MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 321. NETHERLANDS PET CANCER THERAPEUTICS MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 322. NETHERLANDS PET CANCER THERAPEUTICS MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 323. NETHERLANDS PET CANCER THERAPEUTICS MARKET SIZE, BY LINE OF THERAPY, 2018-2024 (USD MILLION)
TABLE 324. NETHERLANDS PET CANCER THERAPEUTICS MARKET SIZE, BY LINE OF THERAPY, 2025-2030 (USD MILLION)
TABLE 325. NETHERLANDS PET CANCER THERAPEUTICS MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 326. NETHERLANDS PET CANCER THERAPEUTICS

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Pet Cancer Therapeutics market report include:
  • Zoetis Inc.
  • Elanco Animal Health Incorporated
  • Virbac S.A.
  • Boehringer Ingelheim International GmbH
  • Ceva Santé Animale S.A.
  • Dechra Pharmaceuticals PLC
  • Vetoquinol S.A.
  • Kindred Biosciences, Inc.
  • VetDC, Inc.
  • OPKO Health, Inc.

Related Topics

Related Reports

Pet Cancer Therapeutics Market Report by Therapy, Animal Species, Cancer Type, End User, and Region 2024-2032 - Product Image

Pet Cancer Therapeutics Market Report by Therapy, Animal Species, Cancer Type, End User, and Region 2024-2032

  • Report
  • 147 Pages
  • Global
From
Pet Cancer Therapeutics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030) - Product Image

Pet Cancer Therapeutics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)

  • Report
  • 113 Pages
  • Global
From
Pet Cancer Therapeutics Global Market Report 2025 - Product Image

Pet Cancer Therapeutics Global Market Report 2025

  • Report
  • 250 Pages
  • Global
From
Veterinary Active Pharmaceutical Ingredients Manufacturing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F - Product Image

Veterinary Active Pharmaceutical Ingredients Manufacturing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F

  • Report
  • 183 Pages
  • Global
From
Pet Noise Anxiety Market by Animal Type (Cats, Dogs, Horses), Product Type (Anxiety Sprays, Audio Devices, Calming Collars), Distribution Channel, Therapeutic Agent - Global Forecast 2025-2030 - Product Image

Pet Noise Anxiety Market by Animal Type (Cats, Dogs, Horses), Product Type (Anxiety Sprays, Audio Devices, Calming Collars), Distribution Channel, Therapeutic Agent - Global Forecast 2025-2030

  • Report
  • 183 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.